Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study.

Michael ToproverBinita ShahCheongeun OhTalia F IgelAaron Garza RomeroVirginia C PikeFatmira CurovicDaisy BangDeana LazaroSvetlana KrasnokutskyStuart D KatzMichael H Pillinger

Published in: Arthritis research & therapy (2020)

Initiating guideline-concordant gout treatment reduces intercritical systemic inflammation and improves endothelial-dependent arterial function, particularly in patients without established cardiovascular comorbidities.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
uric acid
peritoneal dialysis
metabolic syndrome
patient reported outcomes